First-pass extracted concept

engineered natural killer (NK) cells

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

engineered NK cells

Extracted Explainers

What the tool is doing

Engineered NK cells are presented as a therapeutic strategy to target NK-cell plasticity in tumours, with enhanced specificity.

Source 1DOI PubMed

What problem it solves

They are proposed to help counter tumour resistance by leveraging or redirecting NK-cell plasticity in the tumour microenvironment.

Source 1DOI PubMed

What it does not solve

The abstract states that TME heterogeneity and persistent dysfunctional states remain challenges, so this strategy does not by itself eliminate those barriers.

Source 1DOI PubMed

Evidence Snippets

Therapeutic strategies targeting this plasticity include engineered natural killer (NK) cells with enhanced specificity, metabolic restoration approaches and microenvironment-modulating interventions.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1limitationsupports2025Source 1DOI PubMed

TME heterogeneity and persistent dysfunctional NK-cell states remain challenges for therapies targeting NK-cell plasticity.

Claim 2mechanismsupports2025Source 1DOI PubMed

Within the tumour microenvironment, NK cells undergo receptor remodelling with increased inhibitory signals and reduced activating receptors, contributing to dysfunctional NK-cell subsets.

Claim 3therapeutic strategysupports2025Source 1DOI PubMed

Therapeutic strategies targeting NK-cell plasticity in tumours include engineered NK cells with enhanced specificity, metabolic restoration approaches, and microenvironment-modulating interventions.